Malpractice Risk - Mpje

1. A pharmacist correctly fills a prescription but places it in a bag with another patient's medication. The wrong patient takes home the other patient's prescription. No harm results, but the error is discovered. What is the pharmacist's BEST course of action?
   Answer: Inform both patients, correct the error, and document the incident. Even when no immediate harm results, best practice and ethical obligation require notifying affected patients, correcting the error (retrieving misdirected medications, ensuring patients have the correct ones), and documenting the incident for quality improvement. This approach is consistent with the standard of care and transparency principles. Inaction after an identified error - even a non-harmful one - is not appropriate. The error is not a DEA reporting event unless controlled substances were involved in a loss or theft.
2. A pharmacist makes a dispensing error that causes patient harm. The pharmacy's risk manager initiates an internal incident report. Which statement about incident reports is most accurate from a liability perspective?
   Answer: Incident reports are valuable for internal quality improvement; their discoverability in litigation varies by state law Incident reports serve an important internal quality improvement function by capturing error details and enabling systemic fixes. Their discoverability in civil litigation depends on state law - some states provide qualified privilege for peer review and quality improvement documents. They are not categorically discoverable or categorically protected. FDA 15-day reports apply to serious adverse drug events, not pharmacy dispensing errors. Creating incident reports is standard risk management practice.
3. A plaintiff attorney argues that a pharmacy chain's policy of filling 20+ prescriptions per pharmacist per hour creates systemic malpractice risk. Which analysis BEST supports this argument?
   Answer: Excessive workload reduces the time available for DUR, counseling, and verification, increasing the probability of dispensing errors and breaches of the standard of care Excessive workload that prevents pharmacists from performing required clinical functions - DUR, counseling, verification - can constitute a systemic breach of the standard of care. Courts and licensing boards have recognized that unreasonable productivity demands that compromise safety create liability both for the individual pharmacist and, under respondeat superior, for the employer. Liability is not limited to the individual pharmacist when organizational policies create the conditions for error.
4. A hospital pharmacist prepares a chemotherapy infusion with a 10-fold overdose due to a calculation error. The patient dies. Which factor would MOST increase the pharmacy's malpractice exposure in this case?
   Answer: The pharmacy lacked a required double-check process for high-alert medication preparation High-alert medications like chemotherapy require independent double-checks as part of the recognized standard of care. The absence of a required double-check process indicates both a system failure and a deviation from standard practice, significantly increasing liability. A terminal diagnosis does not eliminate liability for errors that hasten death. Technician error does not shield the pharmacist or institution from respondeat superior liability. Lack of insurance affects recovery, not the underlying liability.
5. A retail pharmacist notices a patient picking up a prescription for lithium appears confused and is asking questions suggesting she may not understand the medication. The pharmacist dismisses the patient quickly due to high store volume. The patient later experiences a toxic lithium level. What risk management principle did the pharmacist violate?
   Answer: The pharmacist failed to provide required patient counseling on medication use. A pharmacist's professional duty to counsel -- particularly when a patient appears confused about a high-risk, narrow-therapeutic-index medication such as lithium -- is a recognized standard of care whose breach increases malpractice risk. This duty derives primarily from state pharmacy practice acts and professional standards. Note that OBRA '90 required Medicaid pharmacies to offer counseling to Medicaid patients as a condition of Medicaid reimbursement; most states have since enacted counseling requirements in their pharmacy practice acts that extend to all retail patients. Dismissing a patient who appears confused about a drug with a narrow therapeutic index breaches the applicable standard of care. A is incorrect because USP 800 governs hazardous drug handling and lithium is not classified as a hazardous drug under NIOSH criteria. C is incorrect because HIPAA governs privacy of health information and does not require counseling documentation in this context. D is incorrect because lithium is not a controlled substance and DEA regulations do not govern its dispensing.
6. A pharmacy technician makes a dispensing error that causes patient harm. The supervising pharmacist performed the final verification check but missed the error. How is liability MOST likely allocated?
   Answer: Liability may fall on both the supervising pharmacist and the pharmacy employer. The pharmacist who performed the final verification bears professional responsibility for errors that a competent check should have caught. The pharmacy employer is vicariously liable under respondeat superior for errors committed by employees in the scope of their duties. The technician may also bear individual liability, but the pharmacist's failure to catch the error during verification constitutes an independent breach of duty. The state board adjudicates discipline; it does not share civil liability.
7. A pharmacist is named in a malpractice lawsuit. She has professional liability (malpractice) insurance. What is the PRIMARY benefit of this coverage in this situation?
   Answer: It covers legal defense costs and any damages awarded up to the policy limit Professional liability insurance covers the insured pharmacist's legal defense costs and indemnifies against damages awarded within the policy limits. It does not protect against state board disciplinary proceedings, which are separate regulatory actions. The policy covers the individual pharmacist, not necessarily the employer. The DEA does not require liability insurance as a condition of registration.
8. A compounding pharmacy prepares a sterile ophthalmic preparation that is later found to contain particulate matter. Several patients suffer eye injuries. Which legal theory would MOST likely support strict liability claims against the pharmacy?
   Answer: Strict products liability for distributing a defective compounded product. In jurisdictions that apply strict products liability to pharmacy-compounded preparations, plaintiffs may bring a defective product claim without needing to prove negligence -- only that the product was defective and caused harm. Whether strict products liability applies to a compounding pharmacy varies by state; some states treat pharmacy compounding as a professional service not subject to strict products liability, while others apply it. Among the choices, products liability is the theory most directly aligned with the described harm from a defective preparation. Negligence per se requires an underlying statutory violation as its basis and is not a strict liability theory. Respondeat superior addresses employer/employee liability for an employee's tortious acts, not product defects. Contributory negligence is a defense, not a plaintiff's cause of action.
9. A pharmacist dispenses metformin instead of methotrexate due to a picking error. The patient suffers harm. To succeed in a negligence claim, the patient must prove which four elements?
   Answer: Duty, breach of duty, causation, and damages A negligence claim requires the plaintiff to establish: (1) the defendant owed a duty of care; (2) the defendant breached that duty; (3) the breach caused the plaintiff's injury (causation); and (4) actual damages resulted. The pharmacist-patient relationship establishes duty. Dispensing the wrong drug is a breach. The patient's resulting harm is both the causation link and the damages element.
10. Which legal doctrine holds a pharmacy employer liable for a pharmacist employee's negligent acts committed within the scope of employment?
    Answer: Respondeat superior Respondeat superior ('let the master answer') holds employers vicariously liable for negligent acts of employees performed within the scope of their employment. Res ipsa loquitur infers negligence from the circumstances of an injury. Contributory negligence involves the plaintiff's own fault. Assumption of risk is a defense based on the plaintiff knowingly accepting a risk.
11. A pharmacy chain is considering reducing pharmacist staffing ratios to cut costs. From a malpractice risk management perspective, which analysis BEST supports maintaining adequate staffing?
    Answer: Adequate staffing reduces cognitive load and dispensing errors, lowering malpractice risk. Inadequate staffing is a recognized systemic risk factor for dispensing errors and patient harm. When pharmacists are overwhelmed, they have less time for DUR, counseling, and careful verification - the exact activities that prevent malpractice claims. Courts have held pharmacy employers liable when understaffing created conditions that made compliance with the standard of care impractical. DEA does not regulate pharmacist staffing ratios. SOPs alone cannot compensate for cognitive overload caused by chronic understaffing.
12. A pharmacy implements a barcode scanning system for all dispensed medications to reduce picking errors. This is an example of which type of malpractice risk management strategy?
    Answer: Proactive risk management through system-level error prevention Implementing barcode verification before dispensing is a proactive, system-level strategy designed to prevent errors before they reach the patient. Proactive risk management addresses root causes through process improvement and technology. Reactive management responds after harm occurs. Disciplinary responses address personnel, not system design. While boards may encourage such systems, the question asks about the strategy type.
13. A pharmacist receives a verbal order from a nurse for a controlled substance in a hospital setting. The pharmacist dispenses based on the verbal order but fails to document it. The patient later claims the drug was not authorized. Which risk-reduction practice was neglected?
    Answer: Contemporaneous documentation of the verbal order and follow-up written order Verbal orders in institutional settings require contemporaneous documentation in the patient's record and a written follow-up order from the prescriber. This documentation establishes an auditable record that protects both the pharmacist and the institution. DEA Form 222 applies to Schedule I/II procurement from suppliers, not individual patient dispensing. Patients do not authorize their own prescriptions. MedWatch is for adverse event reporting, not order documentation.
14. A pharmacist discovers she made a dispensing error that has not yet reached the patient. What is the BEST course of action to minimize both patient harm and malpractice risk?
    Answer: Intercept the prescription before it reaches the patient, contact the patient and prescriber, correct the error, and document all actions taken When a dispensing error is caught before it reaches the patient, the pharmacist should intercept the medication, notify the prescriber and patient as appropriate, provide the correct medication, and document all corrective actions. Full disclosure and prompt correction demonstrate adherence to the standard of care and reduce harm. Concealing the error exposes the pharmacist to greater liability. Waiting for adverse effects allows preventable harm. DEA notification applies to controlled substance theft/loss, not routine dispensing errors.
15. A pharmacist receives a prescription for warfarin 10 mg daily - an unusually high dose. The pharmacist dispenses without verifying with the prescriber. The patient experiences a severe bleeding event. What best describes the pharmacist's liability?
    Answer: Potential liability for failing to exercise professional judgment and verify an obviously problematic dose Pharmacists have a professional duty that includes recognizing and acting on clinically significant concerns such as an unusually high dose. Simply filling a prescription as written does not shield the pharmacist from liability when a reasonable pharmacist would have identified the dose as problematic and contacted the prescriber. The doctrine of corresponding responsibility also supports pharmacist liability when filling an apparently erroneous order.
16. A patient suffers harm from a dispensing error and files a malpractice suit. The pharmacy argues the patient's own failure to read the medication guide contributed to the injury. This defense is known as:
    Answer: Comparative or contributory negligence Comparative negligence (in most states) and contributory negligence (in a minority of states) are defenses that reduce or eliminate a defendant's liability when the plaintiff's own negligence contributed to the harm. Arguing that the patient failed to read available safety information may support this defense. Respondeat superior establishes employer liability. Res ipsa loquitur infers negligence from circumstances. Assumption of risk involves knowingly accepting a known danger.
17. A pharmacist counsels a patient about a new anticoagulant and documents the counseling in the pharmacy record. Three months later, the patient claims they were never told about bleeding risks. The documentation serves which primary purpose in litigation?
    Answer: It demonstrates compliance with counseling standards, aiding in legal defense. Contemporaneous documentation of counseling activities is one of the most effective defenses in malpractice litigation. If the record shows the pharmacist counseled the patient about bleeding risks, this evidence supports that the standard of care was met. Documentation does not bar claims entirely, does not transfer liability to the prescriber, and no specific FDA documentation requirement governs anticoagulant counseling in a retail setting.
18. A pharmacist is evaluating whether to implement a new electronic prescription verification software. From a malpractice risk management perspective, which consideration is MOST important?
    Answer: Whether the software reliably reduces dispensing errors and supports pharmacist clinical decision-making without introducing new failure modes From a malpractice risk management standpoint, the critical question is whether the technology effectively reduces errors and enhances safety without creating new failure modes (such as alert fatigue or software glitches that mask errors). Technology that introduces new risks or that pharmacists blindly trust without critical oversight can increase liability. The pharmacist retains responsibility for final verification; software does not eliminate this duty. DEA approval is not required for verification software.
19. A pharmacy receives a prescription for a drug with a narrow therapeutic index. To reduce malpractice risk, which action is MOST important during dispensing?
    Answer: Verify dosing accuracy and counsel the patient on potential toxicity signs. Narrow therapeutic index drugs - such as warfarin, digoxin, lithium, and phenytoin - require heightened vigilance. Verifying the dose, counseling the patient on toxicity signs, and confirming patient identity are directly aligned with the pharmacist's professional duty and the standard of care for high-risk medications. A second written prescription is not required. FDA do-not-compound lists apply to outsourcing facilities. DEA waivers are not a concept in pharmacy practice.
20. What is the standard of care against which pharmacist conduct is measured in a malpractice case?
    Answer: The level of skill and care exercised by a reasonably prudent pharmacist under similar circumstances The legal standard of care in pharmacist malpractice cases is what a reasonably prudent pharmacist would do under the same or similar circumstances. This is typically established through expert witness testimony from practicing pharmacists. It is not judged by physician standards, absolute regulatory compliance, or a specific pharmacy's internal SOPs, though SOPs may be relevant evidence.

Start this quiz